Tekla Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $9.81M | Hold |
67,356
| – | – | 0.38% | 56 |
|
|
2023
Q1 | $8.7M | Sell |
67,356
-191,512
| -74% | -$24M | 0.33% | 63 |
|
|
2022
Q4 | $33M | Hold |
258,868
| – | – | 1.25% | 24 |
|
|
2022
Q3 | $27.1M | Buy |
258,868
+116,824
| +82% | +$12.8M | 1.11% | 26 |
|
|
2022
Q2 | $14.9M | Hold |
142,044
| – | – | 0.59% | 44 |
|
|
2022
Q1 | $18.2M | Sell |
142,044
-4,261
| -3% | -$514K | 0.64% | 41 |
|
|
2021
Q4 | $18M | Sell |
146,305
-83,079
| -36% | -$10.9M | 0.58% | 45 |
|
|
2021
Q3 | $32.6M | Hold |
229,384
| – | – | 1.05% | 29 |
|
|
2021
Q2 | $35.8M | Buy |
229,384
+15,336
| +7% | +$2.48M | 1.16% | 22 |
|
|
2021
Q1 | $33.3M | Sell |
214,048
-6,386
| -3% | -$989K | 1.14% | 22 |
|
|
2020
Q4 | $33M | Buy |
220,434
+22,739
| +12% | +$3.21M | 1.16% | 23 |
|
|
2020
Q3 | $26.1M | Buy |
197,695
+100,202
| +103% | +$13.1M | 0.98% | 27 |
|
|
2020
Q2 | $11.3M | Buy |
97,493
+16,980
| +21% | +$1.96M | 0.43% | 50 |
|
|
2020
Q1 | $7.9M | Buy |
80,513
+14,932
| +23% | +$1.96M | 0.36% | 55 |
|
|
2019
Q4 | $9.53M | Sell |
65,581
-14,317
| -18% | -$1.98M | 0.36% | 62 |
|
|
2019
Q3 | $10.6M | Sell |
79,898
-2,146
| -3% | -$277K | 0.46% | 53 |
|
|
2019
Q2 | $9.38M | Hold |
82,044
| – | – | 0.38% | 60 |
|
|
2019
Q1 | $10.2M | Sell |
82,044
-9,836
| -11% | -$1.12M | 0.41% | 52 |
|
|
2018
Q4 | $9.25M | Sell |
91,880
-30,531
| -25% | -$3.43M | 0.4% | 51 |
|
|
2018
Q3 | $15.6M | Hold |
122,411
| – | – | 0.57% | 44 |
|
|
2018
Q2 | $13.2M | Buy |
122,411
+37,869
| +45% | +$4.12M | 0.5% | 44 |
|
|
2018
Q1 | $8.95M | Buy |
84,542
+1,833
| +2% | +$213K | 0.35% | 63 |
|
|
2017
Q4 | $9.69M | Buy |
82,709
+12,875
| +18% | +$1.46M | 0.37% | 55 |
|
|
2017
Q3 | $7.94M | Sell |
69,834
-35,535
| -34% | -$4.1M | 0.28% | 65 |
|
|
2017
Q2 | $13.1M | Hold |
105,369
| – | – | 0.49% | 47 |
|
|
2017
Q1 | $12.5M | Hold |
105,369
| – | – | 0.48% | 45 |
|
|
2016
Q4 | $10.6M | Hold |
105,369
| – | – | 0.45% | 52 |
|
|
2016
Q3 | $13.3M | Hold |
105,369
| – | – | 0.51% | 46 |
|
|
2016
Q2 | $12.3M | Hold |
105,369
| – | – | 0.5% | 50 |
|
|
2016
Q1 | $10.9M | Hold |
105,369
| – | – | 0.46% | 54 |
|
|
2015
Q4 | $10.5M | Hold |
105,369
| – | – | 0.38% | 56 |
|
|
2015
Q3 | $9.61M | Hold |
105,369
| – | – | 0.35% | 68 |
|
|
2015
Q2 | $11.2M | Hold |
105,369
| – | – | 0.4% | 57 |
|
|
2015
Q1 | $12M | Buy |
105,369
+23,175
| +28% | +$2.64M | 0.48% | 51 |
|
|
2014
Q4 | $9.05M | Hold |
82,194
| – | – | 0.42% | 54 |
|
|
2014
Q3 | $8.02M | Buy |
+82,194
| New | +$8.08M | 0.38% | 58 |
|
Other funds holding ZBH
Tekla Capital Management's ZBH Position: Q2 2023 in Review
Tekla Capital Management held its Zimmer Biomet (ZBH) position steady in Q2 2023 at 67,356 shares worth $9.81M. The position accounts for 0.38% of the portfolio, ranked #56.
Tekla Capital Management first reported a position in ZBH in Q3 2014 and has held it in 36 quarters since. The position peaked at $35.8M in Q2 2021. 1,032 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.
- Tekla Capital Management held 67,356 shares of Zimmer Biomet worth $9.81M as of Q2 2023.
- Tekla Capital Management left its Zimmer Biomet share count unchanged in Q2 2023.
- Zimmer Biomet made up 0.38% of Tekla Capital Management's portfolio in Q2 2023, its #56 holding.
- Tekla Capital Management first reported a position in Zimmer Biomet in Q3 2014 and has held it in 36 quarters since.
- Tekla Capital Management's Zimmer Biomet position peaked at $35.8M in Q2 2021.
- 1,032 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.
Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.